Antiviral therapeutic efficacy of foscarnet in hepatitis B virus infection

Antiviral Research

Volumn 68, Issue 3, 2005, Pages 147-153

  Han, Yan Xing ^a   Xue, Rong ^b   Zhao, Wei ^b   Zhou, Zhen Xian ^b   Li, Jian Nong ^a   Chen, Hong Shan ^a   Chen, Xiang Hong ^a   Wang, Yan Ling ^c   Li, Yu Huan ^a   Wu, Yin Wei ^b   You, Xue Fu ^a   Zhao, Li Xun ^a   Jiang, Jian Dong ^a  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

^b Nanjing Second Hospital   (China)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Antiviral therapy; Foscarnet; HBV infection

Indexed keywords

ASPARTIC ACID; FOSCARNET; GAMMA GLUTAMYLTRANSFERASE; GAN LE XIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; HERBACEOUS AGENT; LAMIVUDINE; LIVER ENZYME; METHIONINE; TYROSINE; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; AGED; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN HEPG2; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA REPLICATION; DRUG EFFICACY; DRUG RESISTANCE; DRUG SCREENING; DUCK; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; KIDNEY FUNCTION; LIVER INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL; VIRUS INFECTION;

ADULT; AGED; ANTIVIRAL AGENTS; CELL CULTURE TECHNIQUES; DRUG THERAPY, COMBINATION; FEMALE; FOSCARNET; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MALE; MIDDLE AGED; TREATMENT OUTCOME;

ANIMALIA; DNA VIRUSES; HEPATITIS B VIRUS; HERPESVIRIDAE;

EID: 27744543423     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2005.09.002     Document Type: Article

References (24)

1. J. Aschan, O. Ringden, P. Ljungman, B. Lonnqvist, and S. Ohlman Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients Scand. J. Infect. Dis. 24 1992 143 150
2. V.G. Bain, H.M. Daniels, A. Chanas, G.J. Alexander, and R. Williams Foscarnet therapy in chronic hepatitis B virus E antigen carriers J. Med. Virol. 29 1989 152 155
3. M. Buti, F. Sanchez, M. Cotrina, R. Jardi, F. Rodriguez, R. Esteban, and J. Guardia Quantitative hepatitis B virus DNA testing for the early prediction of the maintenance of response during lamivudine therapy in patients with chronic hepatitis B J. Infect. Dis. 183 2001 1277 1280
4. Y.J. Chen, J.R. Gu, and H.C. Jiang Direct detection of serum HBV DNA by spot hybridization Chin. J. Infect. Dis. 1 1983 63 67
5. Chinese Clinical Group for HBV infection, 2004. Clinical treatment of HBV with lamivudine. Chin. J. Hepatol. 12, 4-25.
6. E. De Clercq Antiviral drugs in current clinical use J. Clin. Virol. 30 2004 115 133
7. J. Delmas, O. Schorr, C. Jamard, C. Gibbs, C. Trepo, O. Hantz, and F. Zoulim Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro Antimicrob. Agents Chemother. 46 2002 425 433
8. J.S. Freiman, S.M. Murray, K. Vickery, D. Lim, and Y.E. Cossart Postexposure treatment of experimental DHBV infection: a new therapeutic strategy J. Med. Virol. 30 1990 272 276
9. N.M. Gray, C.L. Marr, C.R. Penn, J.M. Cameron, and R.C. Bethell The intracellular phosphorylation of (-)-2′-deoxy-3′-thiacytidine (3TC) and incorporation of 3TC 5′-monophosphate into DNA by HIV-1 reverse transcriptase and human DNA polymerase gamma Biochem. Pharmacol. 50 1995 1043 1051
10. G. Hess, W. Arnold, and K.H. Meyer zum Buschenfelde Inhibition of hepatitis B virus polymerase by phosphonoformate: studies on its mode of action J. Med. Virol. 5 1980 309 316
11. P. Honkoop, R.A. de Man, H.G. Niesters, J. Main, F. Nevens, H.C. Thomas, J. Fevery, D.L. Tyrrell, and S.W. Schalm Quantitative hepatitis B virus DNA assessment by the limiting-dilution polymerase chain reaction in chronic hepatitis B patients: evidence of continuing viral suppression with longer duration and higher dose of lamivudine therapy J. Viral Hepat. 5 1998 307 312
12. J.D. Jiang, A.S. Davis, K. Middleton, Y.H. Ling, R. Perez-Soler, J.F. Holland, and J.G. Bekesi 3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2 and induces apoptosis in tumor cells Cancer Res. 58 1998 5389 5395
13. J.W. Kim, H.S. Lee, G.H. Woo, J.H. Yoon, J.J. Jang, J.G. Chi, and C.Y. Kim Fatal submassive hepatic necrosis associated with tyrosine-methionine- aspartate-aspartate motif mutation of hepatitis B virus after long-term lamivudine therapy Clin. Infect. Dis. 33 2001 403 405
14. C.L. Lai, V. Ratziu, M.F. Yuen, and T. Poynard Viral hepatitis B Lancet 362 2003 2089 2094
15. k.Q. Luo, X.Y. Jing, and J.S. Hua Hepatic necrosis in HBV infection during lamivudine treatment Chin. J. Lab. Clin. Virol. 4 2001 234 237
16. R.R. MacGregor, A.L. Graziani, R. Weiss, J.E. Grunwald, and J.G. Gambertoglio Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring J. Infect. Dis. 164 1991 785 787
17. J.S. McMillan, T. Shaw, P.W. Angus, and S.A. Locarnini Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro Hepatology 22 1995 36 43
18. P.M. Price, R. Banerjee, and G. Acs Inhibition of the replication of hepatitis B virus by the carbocyclic analogue of 2′-deoxyguanosine Proc. Natl. Acad. Sci. U.S.A. 86 1989 8541 8544
19. L.V. Rubinstein, R.H. Shoemaker, K.D. Paull, R.M. Simon, S. Tonisi, P. Skehan, D.A. Scudiero, A. Monks, and M.R. Boyd Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines J. Natl. Cancer Inst. 82 1990 1113 1118
20. R. Schvarcz, B.G. Hansson, J.O. Lernestedt, and O. Weiland Treatment of chronic replicative hepatitis B virus infection with short-term continuous infusion of foscarnet Infection 22 1994 330 332
21. M.A. Sells, M.L. Chen, and G. Acs Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA Proc. Natl. Acad. Sci. U.S.A. 84 1987 1005 1009
22. Y.M. Wen Laboratory diagnosis of viral hepatitis in China: the present and the future Clin. Chem. Lab. Med. 39 2001 1183 1189
23. Y. Yao, N. Tang, and A. Huang Study on the replication of hepatitis B virus compared with that of duck hepatits B virus in primary duck hepatocytes Zhonghua Yi Xue Za Zhi 81 2001 1157 1161
24. J. Zemlicka Enantioselectivity of the antiviral effects of nucleoside analogues Pharmacol. Ther. 85 2000 251 266